Immunotherapy in metastatic non-small cell lung cancer: EPSILoN as a prognostic score

被引：0
|
作者：
Valente, M. C. Alves [1 ]
Serino, M. [1 ]
Freitas, C. [1 ,2 ]
Martins, M. [1 ]
Ferreira, P. [1 ]
Cardoso, C. [1 ]
Sousa, C. [1 ,2 ]
Santos, V. [1 ,2 ]
Araujo, D. [1 ,2 ]
Novais-Bastos, H. [1 ,2 ]
Magalhaes, A. [1 ]
Queiroga, H. [1 ,2 ]
Fernandes, G. [1 ,2 ]
Hespanhol, V. [1 ,2 ]
机构：
[1] Ctr Hosp & Univ Sao Joao, Pulmonol Dept, Porto, Portugal
[2] Univ Porto, Fac Med, Porto, Portugal
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Lung cancer - management; Biomarkers; Treatments;
D O I：
10.1183/13993003.congress-2022.3572
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3572
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EPSILoN score: Validation cohort of a prognostic score in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapy
    Prelaj, A.
    Lo Russo, G.
    Signorelli, D.
    Ferrara, R.
    Imbimbo, M.
    Galli, G.
    De Toma, A.
    Randon, G.
    Brambilla, M.
    Trevisan, B.
    Ganzinelli, M.
    Zilembo, N.
    De Braud, F.
    Garassino, M. C.
    Proto, C.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 59 - 59
  • [2] Immunotherapy of metastatic non-small cell lung cancer
    Sackmann, Sandra
    Ogundele, Samuel
    Ukena, Dieter
    [J]. PNEUMOLOGE, 2019, 16 (06): : 353 - 365
  • [3] EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort
    Prelaj, Arsela
    Ferrara, Roberto
    Rebuzzi, Sara Elena
    Proto, Claudia
    Signorelli, Diego
    Galli, Giulia
    De Toma, Alessandro
    Randon, Giovanni
    Pagani, Filippo
    Viscardi, Giuseppe
    Brambilla, Marta
    Trevisan, Benedetta
    Ganzinelli, Monica
    Martinetti, Antonia
    Gallucci, Rosaria
    Di Mauro, Rosa Maria
    Molino, Giuliano
    Zilembo, Nicoletta
    Torri, Valter
    de Braud, Filippo Maria
    Garassino, Marina Chiara
    Lo Russo, Giuseppe
    [J]. CANCERS, 2019, 11 (12)
  • [4] Pretreatment predictive score for metastatic non-small cell lung cancer patients treated with immunotherapy
    Musaelyan, A.
    Moiseyenko, F.
    Emileva, T.
    Oganesyan, A. P.
    Urtenova, M.
    Odintsova, S.
    Chistyakov, I.
    Akopov, A.
    Orlov, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S77 - S77
  • [5] NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score
    Song, Peng
    Yang, Dongliang
    Cui, Xiaoxia
    Wang, Hanping
    Si, Xiaoyan
    Zhang, Xiaotong
    Zhang, Li
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5975 - 5985
  • [6] Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
    Barnet, Megan B.
    Cooper, Wendy A.
    Boyer, Michael J.
    Kao, Steven
    [J]. JOURNAL OF CLINICAL MEDICINE, 2018, 7 (06)
  • [7] The Scottish Immunotherapy Prognostic Score (SIPS) Predicts Response to First-Line Pembrolizumab for Metastatic Non-Small Cell Lung Cancer
    Stares, M.
    Ding, T.
    Stratton, C.
    Thomson, F.
    Mackean, M.
    Cumming, K.
    Barrie, C.
    Maclennan, K.
    Campbell, S.
    Evans, T.
    Tufail, A.
    Phillips, I.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1139 - S1140
  • [8] Lymphopenia: Is it a prognostic factor in metastatic non-small cell lung cancer?
    El Mekkeoui, Zineb Benbrahim
    Arifi, Samia
    Amaadour, Lamiae
    Abda, Naima
    Nejjari, Chakib
    Nawfel, Mellas
    El Mesbahi, Omar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] METASTATIC LOCATIONS IN NON-SMALL CELL LUNG CANCER AND THEIR PROGNOSTIC SIGNIFICANCE
    Diaconescu, Razvan
    Payette, Genevieve
    Rodgers, Valerie
    Fortin, Bernard
    Lafond, Chantal
    Whittom, Renaud
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1280 - S1281
  • [10] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
12345